RegisterLogin

Tanomastat

CAT: 0804-HY-12168Size: 500 µgDry Ice: NoHazardous: No
CAT#:0804-HY-12168Size:500 µg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Tanomastat (BAY 12-9566) is an orally bioavailable, non-peptidic biphenyl matrix metalloproteinases (MMPs) inhibitor with a Zn-binding carboxyl group. The Ki values are 11, 143, 301, and 1470 nM for MMP-2, MMP-3, MMP-9, MMP-13 respectively. Tanomastat shows anti-invasive and antimetastatic activity in several experimental tumor models[1][2][3].
CAS Number
[179545-77-8]
Product Name Alternative
BAY 12-9566
UNSPSC
12352005
Hazard Statement
H302, H312, H332
Target
MMP
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tanomastat.html
Purity
99.7
Solubility
DMSO : 25 mg/mL (ultrasonic; warming)
Smiles
ClC1=CC=C(C2=CC=C(C(C[C@H](CSC3=CC=CC=C3)C(O)=O)=O)C=C2)C=C1
Molecular Formula
C23H19ClO3S
Molecular Weight
410.91
Precautions
H302, H312, H332
References & Citations
[1]Leung D, et al. Protease inhibitors: current status and future prospects. J Med Chem. 2000 Feb 10;43 (3) :305-41.|[2]Gatto C, et al. BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity. Clin Cancer Res. 1999 Nov;5 (11) :3603-7.|[3]Nozaki S, et al. Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 in a human breast cancerorthotopic model. Clin Exp Metastasis. 2003;20 (5) :407-12.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
MMP-13; MMP-2; MMP-3; MMP-9

Related Products

CatalogName

Alternative Products

CatalogName
M12711-01Tanomastat
T62090-01(Rac) -Tanomastat
MBS5804779(Rac)-Tanomastat
MBS6092864-01Tanomastat (BAY 12-9566, (S)-4'-Chloro-g-oxo-a-[(phenylthio)methyl][1,1'-biphenyl]-4-butanoic Acid)

Popular Products